Drug combo shows promise in bile duct cancer with mutations

Written by | 8 Nov 2020

Dabrafenib plus trametinib combination appears to be a promising treatment for patients with bile duct cancer (biliary tract cancer) with BRAF V600E mutations. Researchers reported these findings on August […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.